Inflammation of adipose tissue in obesity is associated with increased IL-1β, IL-6 and TNF-α secretion and proposed to contribute to insulin resistance. AMP-activated protein kinase (AMPK) regulates nutrient metabolism and is reported to have anti-inflammatory actions in adipose tissue, yet the mechanisms underlying this remain poorly characterised. The effect of AMPK activation on cytokine-stimulated proinflammatory signalling was therefore assessed in cultured adipocytes. AMPK activation inhibited IL-1β-stimulated CXCL10 secretion, associated with reduced interleukin-1 receptor associated kinase-4 (IRAK4) phosphorylation and downregulated MKK4/JNK and IKK/IκB/NFκB signalling. AMPK activation inhibited TNF-α-stimulated IKK/IκB/NFκB signalling but had no effect on JNK phosphorylation. The JAK/STAT3 pathway was also suppressed by AMPK after IL-6 stimulation and during adipogenesis. Adipose tissue from AMPKα1 -/-mice exhibited increased JNK and STAT3 phosphorylation, supporting suppression of these distinct proinflammatory pathways by AMPK in vivo. The inhibition of multiple pro-inflammatory signalling pathways by AMPK may underlie the reported beneficial effects of AMPK activation in adipose tissue.
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INTRODUCTION
Obesity is associated with chronic low-grade inflammation of white adipose tissue (WAT), in which there is upregulated secretion of the pro-inflammatory cytokines TNF-α, IL-1β and IL-6. Plasma concentrations of these pro-inflammatory cytokines have been reported to be elevated in obese individuals (Lee et al., 2009) . TNF-α and IL-1β trigger pro-inflammatory effects via simultaneous activation of the nuclear factor kappa B (NFκB) and multiple mitogen-activated protein kinase (MAPK) intracellular signalling pathways. IL-1β binding leads to recruitment of adapter proteins that further recruit IL-1 receptor associated kinase (IRAK) family members, directly interacting with IRAK4 which autophosphorylates and activates the downstream kinases IRAK1 and IRAK2.
IRAK activation further stimulates formation of a signalosome including TNF receptorassociated factor-6 (TRAF6), TGFβ-activated kinase-1 (TAK1) and IκB kinase (IKK) (Salt & Palmer, 2012) . TNF-α engages multiple complex ubiquitin-dependent processes that also stimulate TAK1 and IKK (Salt & Palmer, 2012) . IKK stimulates the phosphorylation of inhibitor of NFκB (IκBα), targeting IκB for proteasomal degradation and thereby releasing active NFκB dimers, with p65-p50 heterodimers being the principal form activated by the canonical NFκB pathway in response to TNF-α and IL-1β (Cohen, 2014; Brenner et al., 2015; Salt & Palmer, 2012) . The p65-p50 heterodimers subsequently translocate into the nucleus to bind κB-responsive elements in the promoters of target genes, including other pro-inflammatory cytokines and chemokines.
TNF-α and IL-1β stimulate activation of pro-inflammatory MAPKs, such as the c-jun Nterminal kinase (JNK) pathway, in parallel with NFκB activation (Cohen, 2014; Salt & Palmer, 2012) .
In contrast, IL-6 elicits its effects via binding a membrane-bound IL-6 receptor complexed with the co-receptor gp130 (classic signalling), or by binding a soluble receptor (sIL-6Rα) that binds to gp130 (trans-signalling), stimulating Janus kinase (JAK)-mediated activation of the signal transducer and activator of transcription-3 (STAT3) transcription factor predominantly via phosphorylation of Tyr705 (Salt & 
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4 activated' pro-inflammatory state, which has been reported to dominate in WAT in obesity (Lumeng et al., 2007) .
Increased ATP consumption and/or decreased ATP synthesis, leads to an increase in ADP:ATP and AMP:ATP ratios that activate the heterotrimeric Ser/Thr protein kinase AMP-activated protein kinase (AMPK) (Salt & Palmer, 2012; Bijland et al., 2013) .
Activated AMPK phosphorylates target proteins that act to normalise ATP concentrations by stimulating ATP-generating pathways such as fatty acid oxidation, mitochondrial biogenesis and muscle glucose transport, whilst inhibiting ATPconsuming anabolic pathways including protein translation, fatty acid and cholesterol synthesis (Salt & Palmer, 2012; Bijland et al., 2013) . In adipose tissue, AMPK suppresses adipogenesis, fatty acid and triglyceride synthesis (Bijland et al., 2013) .
More recently, AMPK has been reported to have anti-inflammatory actions independent of its metabolic effects, diminishing immune responses in a range of in vivo models of inflammation (Salt & Palmer, 2012) . Although AMPK-dependent inhibition of proinflammatory signaling has been reported in preadipocytes, macrophages and vascular cells (Jeong et al., 2009; Sag et al, 2008; Ewart et al., 2008; Chen et al., 2016) , all of which are present in significant quantities in intact adipose tissue, AMPK-dependent suppression of pro-inflammatory signalling in adipocytes remains poorly characterised.
Various AMPK activators have been reported to reduce pro-inflammatory cytokine expression and NFκB activation in adipose tissue from rodents (Jeong et al., 2009; Sun et al., 2014) and inhibit expression and secretion of pro-inflammatory cytokines in human subcutaneous WAT cultured ex-vivo (Lihn et al., 2004; Lihn et al., 2008) .
Importantly, however, these studies did not examine the effect of AMPK activation in adipocytes themselves or demonstrate the AMPK-dependence of the AMPK activators used. This is critical due to the non-specific nature of and AMPK-independent effects reported for several widely-used AMPK activators, including AICAR, phenformin and metformin (Garcia-García et al., 2010; Guigas et al., 2006) . Three studies have reported inhibition of IKKβ phosphorylation in cultured adipocytes or rodent adipose tissue by AMPK activators in a manner sensitive to compound C, which has been used widely to imply AMPK-dependence Zhao et al., 2014; Chen et al., 2016) .
Compound C is a poorly-selective inhibitor of AMPK, with many reported AMPKindependent effects and inhibiting several protein kinases other than AMPK with similar or greater potency (Salt & Palmer, 2012; Bain et al., 2007) . Indeed, compound C has been demonstrated to influence pro-inflammatory signalling independent of AMPK (Kim et al., 2011) .
As AMPK is activated by several existing drugs used to treat type 2 diabetes, including metformin and thiazolidinediones (Bijland et al., 2013) , there is a need to understand the actions of AMPK activation in metabolic tissues. Therefore, given the proposed antiinflammatory actions of AMPK and dearth of information concerning the role of AMPK in adipocyte pro-inflammatory signalling, we investigated the effect of AMPK activation on pro-inflammatory signalling in response to IL-1β, TNF-α and IL-6, the principal cytokines associated with adipose tissue inflammation, in cultured adipocytes using the selective AMPK activator A769662, which directly binds and activates AMPK heterotrimers containing the β1 non-catalytic subunit (Scott et al., 2008) . We also examined basal pro-inflammatory signalling pathway status in adipose tissue lacking the AMPKα1 catalytic subunit.
MATERIALS AND METHODS
Materials
3T3-L1 preadipocytes which overexpress the coxsackie virus and adenovirus receptor (3T3-L1∆1CAR) (Ross et al., 2003) were a kind gift from Prof. David Orlicky, University of Colorado (CO, USA). Adenoviruses expressing c-myc-tagged dominant negative mutant AMPKα1 (Ad.α1-DN), constitutively active AMPKα1 (Ad.AMPK-CA), GFP (Ad.GFP) and control adenoviruses (Ad.null) have been described previously (Woods et al., 2000) , and were a generous gift from Dr F. Goat anti-rabbit Alexa Fluor 488 secondary antibody was from Invitrogen (Paisley, UK).
Mouse cytokine 20-plex panel for Luminex platform was obtained from Invitrogen (Paisley, UK). All other reagents were from sources described previously (Ewart et al., 2008; Boyle et al., 2011) .
Cell Culture
3T3-L1 and 3T3-L1∆1CAR fibroblasts were cultured and differentiated into adipocytes as described previously (Boyle et al., 2011) .Human SW872 cells were cultured and differentiated into adipocytes as described previously (Rios et al., 2015) . Mouse embryonic fibroblasts (MEFs) lacking AMPKα1 and AMPKα2 (Laderoute et al., 2006) and wild-type control MEFs were cultured in DMEM and 10% (v/v) FCS. 3T3-L1 preadipocytes were used between passages 8 and 12 and 8-12 days post differentiation. 3T3-L1∆1 CAR preadipocytes were used between passages 15 and 30 and 8-12 days post differentiation. SW872 adipocytes were stimulated on day 9 postdifferentiation having been serum-deprived overnight in DMEM and 1% (v/v) NCS.
Preparation of adenoviruses and infection of 3T3-L1∆1CAR adipocytes
Ad.α1-DN, Ad.AMPK-CA, Ad.GFP and Ad.null were propagated, purified and titred as described previously (Ewart et al., 2008) . 3T3-L1∆1CAR adipocytes were infected on day 6 post-differentiation with adenoviruses in serum-free DMEM. After incubation for 4 h, DMEM supplemented with 20% (v/v) FCS was added to achieve 10% (v/v) final concentration and the cells incubated for a further 48 h prior to preparation of cell lysates.
Confocal immunofluorescence microscopy
Coverslips of 3T3-L1 or 3T3-L1∆1CAR adipocytes were washed with PBS and fixed in 
RNA extraction from SW872 adipocytes and gene expression analysis
RNA was extracted from SW872 adipocytes using an RNeasy kit (Qiagen). Between 400-1000 ng of RNA was reverse-transcribed using the High Capacity cDNA Reverse
Transcription kit (Applied Biosystems). qPCR was performed with an Applied
Biosystems ABI-PRISM 7900HT Sequence Detection System. Gene expression was normalized to TATA binding protein (TBP) using Assays on Demand and QPCR master mix (Applied Biosystems). The following TaqMan® Gene Expression Assays (Applied Biosystems) were used: TBP (Hs00427620_m1) and CXCL10 (Hs01124251_g1).
Preparation of cell lysates, SDS PAGE and immunoblotting
Cell lysates were prepared, proteins resolved by SDS-PAGE and subjected to quantitative immunoblotting with the antibodies indicated as described previously (Boyle et al., 2011) . Immunolabelled proteins were visualized using infrared dye-labelled secondary antibodies and an Odyssey Sa infrared imaging system (LiCor Biosciences
Oil Red O staining of 3T3-L1 adipocytes
3T3-L1 adipocytes cultured on glass coverslips were incubated in the presence or absence of A769662 (300 µmol/l). At various intervals from the point of differentiation, cells were fixed using 10% (v/v) formalin for 1 h, then washed once in 60% (v/v) isopropanol and left to dry completely. Coverslips were incubated in 5.1 mmol/l Oil Red O in 60% (v/v) isopropanol for 10 min before washing four times with dH 2 0 and left to dry. Dry coverslips were then dipped in Mayers Hematoxylin (194 mmol/l KAl(SO 4 ) 2 , 16.5 mmol/l hematoxylin, 2 mmol/l NaIO 3 , 2% (v/v) acetic acid), followed by 3% (v/v) NH 4 OH for 10 s. Coverslips were mounted onto slides and images captured using an Axiovision light microscope.
Animals
Female AMPKα1 -/-and wild-type sv129 mice (Jørgensen et al., 2004) were housed in a 12-hour light dark cycle with access to food (normal chow diet) and water ad libitum. All experimental procedures were performed in accordance with UK Home Office Guidance on the operation of the Animals (Scientific Procedures) Act (1986), the "Guide for the Care and Use of Laboratory Animals" published by the US National Institutes of Health (eighth edition) and institutional ethical approval (PPL 70/8572, PPL60/4224).
Glucose tolerance test
Intraperitoneal glucose tolerance test was performed on 18-20 week old mice. Mice were fasted for 16 hours prior to 1g/kg intraperitoneal injection of D-glucose in 0.9% saline (Sigma). Blood glucose levels were measured from tail samples with a glucometer (Freestyle Optium Xceed; Abbott, Berkshire,UK) at 0, 15, 30, 60 90 and 120 minutes.
Preparation of adipose tissue lysates
Mice (aged 18-20 weeks) were killed by cervical dislocation. Subcutaneous and gonadal adipose tissue was excised and snap-frozen prior to preparation of lysates as described previously (Boyle et al., 2011) .
Statistics
Results are expressed as mean ± SEM. Statistically significant differences were determined using a two-tail t-test, or one or two-way ANOVA where appropriate, with p < 0.05 as significant.
RESULTS:
Stimulation of 3T3-L1 adipocytes with 300-1000 µmol/l A769662 or 1 mmol/l AICAR significantly stimulated AMPK activity (Fig 1A) , such that 300 µmol/l was used for subsequent experiments. The stimulatory effect of A769662 was observed after 30 min incubation ( Fig 1B) To determine the effect of A769662 on chemokine secretion, 3T3- secretion (Fig 1C-E) . Furthermore, pre-incubation of human SW872 adipocytes with A769662 or the chemically-unrelated AMPK activator AICAR attenuated IL-1β-stimulated CXCL10 mRNA expression, at concentrations that activated AMPK activity, as assessed by phosphorylation of the AMPK substrate, ACC (Fig 2) .
CXCL10, CXCL1 and MCP1 expression are stimulated by the transcription factor NFκB and/or the AP-I transcription factor complex which includes c-Jun. IL-1β stimulated the translocation of NFκB p65 to the nucleus of 3T3-L1∆1CAR adipocytes, an effect markedly attenuated by preincubation for 30 min with A769662 (Fig 3A, 3B ). A769662-mediated inhibition of NFκB p65 nuclear translocation was ablated in 3T3-L1∆1CAR
adipocytes infected with a dominant-negative AMPKα1 mutant (Ad.α1-DN) (Fig 3C-E) .
Efficiency of adenoviral infection with Ad.α1-DN was estimated to be approximately 60-70% and A769662-stimulated ACC phosphorylation was ablated in cells infected with
Ad.α1-DN, as assessed by myc immunoreactivity (Supplemental Figure 1A) . Infection with Ad.α1-DN was not sufficient to inhibit A769662-stimulated ACC phosphorylation in total 3T3-L1 adipocyte cell lysates, however (data not shown). Furthermore, IL-1β-stimulated p65 translocation was not observed in 3T3-L1∆1CAR adipocytes infected M A N U S C R I P T
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with a constitutively active AMPK mutant (Supplemental Fig 1B, 1C) . Preincubation of 3T3-L1 adipocytes with A769662 significantly attenuated IL-1β-stimulated JNK, IKK and IκB phosphorylation (Fig 4) . Furthermore, A769662 stimulation inhibited both activating phosphorylation of the JNK kinase MKK4 in addition to autophosphorylation of the most upstream kinase in IL-1β signalling, IRAK4 (Fig 4) .
Similar results were obtained when TNF-α was used as the pro-inflammatory stimulus at concentrations previously demonstrated to activate adipocyte proinflammatory signalling (Rotter et al., 2003) , with A769662 attenuating TNF-α-stimulated CXCL10 mRNA expression ( Supplemental Fig 2) , NFκB p65 nuclear translocation (Supplemental Fig 3) and IκB phosphorylation (Supplemental Fig 4) in cultured adipocytes. A769662 had no effect, however, on TNF-α-stimulated JNK phosphorylation (Supplemental Fig   4) . Neither IL-1β nor TNF-α had any effect on basal or A769662-stimulated AMPK activity, as assessed by ACC phosphorylation (Fig 4, Supplemental Fig 4) . phosphorylation stimulated by a sIL-6Rα/IL-6 trans-signalling complex in 3T3-L1 adipocytes (Fig 6) . sIL-6Rα/IL-6 had no effect on ACC phosphorylation (Fig 6) .
Stimulation of 3T3-L1 adipocytes in the presence of IL-6 but without sIL-6Rα had no effect on STAT3 Tyr705 phosphorylation (data not shown). To examine whether A769662 stimulated tyrosine phosphatases, thereby reducing IL-6-stimulated STAT3 phosphorylation, the capacity of A769662 to inhibit IL-6-stimulated STAT3 phosphorylation was examined in 3T3-L1 adipocytes preincubated with the tyrosine phosphatase inhibitor orthovanadate. Incubation with orthovanadate markedly increased IL-6-stimulated STAT3 Tyr705 phosphorylation, yet this was still markedly inhibited by A769662, indicating that AMPK-mediated inhibition is at the level of JAK activity rather than reduced STAT3 phosphatase activity (Supplemental Fig 5) In contrast to IL-1β, sIL-6Rα/IL-6-stimulation of 3T3-L1∆1CAR adipocytes did not produce detectable changes in cytokine/chemokine production (data not shown). Thus to examine the effect of AMPK activation on a JAK-STAT mediated phenomenon in
adipocytes, the effect of A769662 on adipogenesis was examined. STAT3 Tyr705 phosphorylation occurred 24-48h post-differentiation in 3T3-L1 adipocytes, an effect that was significantly reduced in the presence of A769662 (Fig 7) . A769662 had no significant effect on the early increase in expression of CEBPβ or CEBPδ during differentiation, but did suppress the later (day4 onward) increase in CEBPα and PPARγ (Fig 7) . A769662 markedly inhibited the accumulation of triglyceride during adipogenesis, as assessed by oil red O staining (Fig 7) .
To determine the significance of the suppressive effects of AMPK on inflammatory signalling pathway status in adipose tissue in vivo, JNK and STAT3 phosphorylation
were assessed in subcutaneous and gonadal adipose tissue from AMPKα1 -/-mice and their wild-type littermates. Fasting blood glucose, mass and glucose tolerance were not significantly different between genotypes (Supplemental Fig 6) . Basal levels of both JNK and STAT3 phosphorylation were significantly increased in gonadal adipose tissue of AMPKα1 -/-mice relative to wild-type littermates. Basal STAT3 phosphorylation was also significantly increased in subcutaneous adipose tissue, with JNK phosphorylation approaching significance (p=0.054) (Fig 8) .
DISCUSSION
The principal findings of the study are that AMPK activation in adipocytes inhibits 
Inhibition of IKK-IκB-NFκB signalling by AMPK
In macrophages and macrophage cell lines, AMPK-dependent inhibition of IκBα degradation and NFκB DNA binding has been reported (Sag et al., 2008; Yang et al., 2010) . Furthermore, increased nuclear NFκB p65 levels have been reported in endothelial cells from mice deficient in AMPK subunits (Wang et al., 2010) . proposed to inhibit NFκB signalling via phosphorylation of the transcriptional coactivator p300, which blocks activating acetylation of NFκB p65 (Zhang et al., 2011) , however this report did not investigate the effect of AMPK activation upstream of NFκB.
Alternatively, AMPK has also been proposed to hyperphosphorylate and inactivate IKK, thereby suppressing NFκB signalling (Bess et al., 2011) . The findings in the current study do not fully support either of these mechanisms, as the rapid A769662-mediated inhibition of the NFκB pathway is associated with inhibition of activating IKK phosphorylation in adipocytes rather than hyperphosphorylation.
AMPK-mediated inhibition of JNK phosphorylation
Whether AMPK negatively regulates proinflammatory JNK signalling is far less well characterised. AMPK-dependent inhibition of JNK phosphorylation has been reported in macrophages (Jeong et al., 2009 ) and increased JNK phosphorylation has been reported in macrophages and endothelial cells from mice deficient in AMPK subunits (Galic et al., 2011; Dong et al., 2010) . The AMPK activator AICAR has been previously reported to supress basal JNK phosphorylation in 3T3-L1 adipocytes and adipose tissue of mice (Miyokawa-Gorin et al., 2012; Shibata et al., 2013) . Despite this, the mechanism by which AMPK inhibits activating JNK phosphorylation has not been reported. In the current study, A769662 directly inhibited phosphorylation of the JNK kinase MKK4 in MEFs in an AMPK-dependent manner, demonstrating the inhibition is not due to increased JNK phosphatase activity. This is in agreement with indirect evidence in a study published when this manuscript was in preparation, in which hearts of mice with a cardiac-specific knock in of a kinase-dead AMPK were reported to exhibit increased MKK4 phosphorylation after ischaemia-reperfusion (Zaha et al., 2016) . Furthermore, we
show increased basal JNK phosphorylation in adipose tissue depots from mice lacking M A N U S C R I P T
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AMPKα1, reinforcing the negative regulation of pro-inflammatory JNK signalling by AMPK in vivo. Intriguingly, A769662 was unable to suppress TNF-α-stimulated JNK phosphorylation in 3T3-L1 adipocytes, indicating a cytokine-specific effect of AMPK activation. This is in agreement with previous studies where AICAR inhibited TNF-α-stimulated ERK1/2 phosphorylation without impairing JNK phosphorylation in 3T3-L1
adipocytes (Shibata et al., 2013) and A769662 inhibited palmitate-stimulated IKK phosphorylation without influencing JNK phosphorylation in L6 myotubes (Green et al., 2011) . Taken together with the current study, this suggests inhibition of MKK4/JNK and IKK/IκB/NFκB pathways is not mediated by a common AMPK target shared by both pathways.
AMPK-mediated inhibition of IRAK4 phosphorylation
We demonstrate that A769662 stimulation inhibits IL-1β-stimulated phosphorylation of IRAK4 at Thr345/Ser346, a proximal event in IL-1β signalling that is not common with TNF-α signalling (Flannery & Bowie, 2010; Salt & Palmer, 2012) . This shows that AMPK activation impairs IL-1β signalling at a more early stage than previously reported. It is feasible; therefore, that inhibition of JNK signalling by AMPK activation is dependent on impaired IRAK4 autophosphorylation. As IRAK4 phosphorylation is a signalling event shared by several toll-like receptors (Flannery & Bowie, 2010) , AMPK activation should also inhibit signalling by other inflammatory stimuli that utilise IRAK4.
Inhibition of JAK-STAT signalling by AMPK
IL-6-stimulated STAT3 phosphorylation has been reported in liver-derived cells, which utilise the classical membrane-bound IL-6 receptor (Nerstedt et al., 2013; Kim et al., 2012) . In contrast, IL-6 was only effective in 3T3-L1 adipocytes when administered with sIL-6Rα, demonstrating they utilise IL-6 trans-signalling. Furthermore, we demonstrate that A769662-mediated inhibition of STAT3 phosphorylation occurred 24-48h postdifferentiation in the mitotic clonal expansion (MCE) phase concomitant with reduced lipid accumulation. Transient elevation in STAT3 phosphorylation in the MCE phase is essential for adipocyte differentiation (Wang et al., 2009 ). This represents an earlier mechanism by which AMPK activation may inhibit adipogenesis than the reduced expression of later adipogenic markers previously reported (Habinowski & Witters, 2001) . AMPK activation by A769662 rapidly attenuates IL-6-stimulated STAT3 phosphorylation in the presence of the tyrosine phosphatase inhibitor vanadate, indicating an effect on JAK activity, in agreement with studies in liver cell lines (Nerstedt M A N U S C R I P T 14 et al., 2013) . This is further corroborated by recent studies in our laboratories that have demonstrated that AMPK can directly phosphorylate Ser515 and Ser518 in JAK1 in vitro, and that mutation of the Ser residues to Ala ablates AMPK-mediated inhibition of JAK1-STAT signalling in intact cells (Rutherford et al., 2016) . A769662-mediated inhibition of JAK activity via phosphorylation of Ser515/518 is therefore likely to underlie the inhibition of both IL-6 signalling and adipogenic JAK-STAT signalling. (Alomar et al., 2015) . The latter study also reported IL-1β-stimulated secretion of IL-2, IL-4, IL-6, IL-10, IL-13, IL-17, IFN-γ, TNF-α, VEGF and GM-CSF, which was not observed in the current study (Alomar et al., 2015) . The reason for the discrepancy may reflect the two different cell models, shorter exposure to IL-1β in our study or differential sensitivity of the assays utilised. CXCL10 is transcriptionally regulated by NFκB and pro-inflammatory MAPK signalling (Thiefes et al., 2005) . As A769662 had no effect on TNF-α-stimulated JNK phosphorylation yet robustly inhibited CXCL10 mRNA expression, this may suggest that inhibition of the IKK-IκB-NFκB pathway underlies the inhibition in TNF-α-stimulated cells.
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Inhibition of cytokine/chemokine synthesis by AMPK activation
Increased proinflammatory signalling in adipose tissue from mice with reduced AMPK levels
As increased JNK and STAT3 phosphorylation was observed in adipose tissue depots from mice lacking AMPKα1, this indicates that these distinct pro-inflammatory signalling al., 2013). As the mouse adipose used in the current study is from mice globally deficient in AMPKα1, the increased basal JNK and STAT3 phosphorylation observed may be a consequence of impaired AMPK activity in adipocytes, macrophages or other stromal-vascular cells. The effect was not due to differences in mass or glucose tolerance, which was unaltered between genotypes. Mice with adipocyte-specific deletion of AMPKα1, AMPKα2, AMPKβ1 and AMPKβ2 have recently been described (Wu et al., 2015; Motillo et al., 2016) which would prove useful in order to further characterise the anti-inflammatory actions of AMPK in adipose.
Activation of AMPK in adipocytes
The concentration of A769662 (300µmol/l) required for activation of AMPK in 3T3-L1 adipocytes and SW872 adipocytes is higher than that previously reported in several other tissues and cell types (Göransson et al., 2007; Foretz et al., 2010) , although this concentration does not inappropriately alter AMP:ATP ratios in HEK293 cells (Hawley et al., 2010) . As a few studies have reported AMPK-independent effects of A769662 in other cell types (Garcia-García et al., 2010; Benziane et al., 2009; Moreno et al., 2008) , the demonstration of AMPK-dependent inhibition of signalling using dominant negative mutant AMPK and MEFs lacking AMPK establishes the AMPK dependence of these effects.
Reduced AMPK activity has been reported in metabolic tissues of animal models of insulin resistance and obesity Coughlan et al., 2014) . Furthermore, reduced AMPK activity has been reported in adipose tissue of insulin resistant volunteers compared with BMI-matched insulin sensitive controls (Gauthier et al., 2011) and weight loss is associated with increased adipose tissue AMPK activity and insulin sensitivity (Fritzen et al., 2015; Xu et al., 2015) , although SCAT TNF-α and IL-1β mRNA levels were unchanged after weight loss (Xu et al., 2015) . Multiple lines of evidence suggest activation of AMPK is a useful therapeutic aim in obesity and insulin resistance.
Activation of adipose tissue AMPK is feasible, as previous work in our laboratory has
shown that metformin stimulated AMPK activity in SCAT of individuals with type 2 diabetes (Boyle et al., 2011) .
Conclusions
Taken together, our data demonstrate that AMPK activation is associated with multiple anti-inflammatory actions in adipocytes including inhibition of IL-1β-stimulated IRAK4
phosphorylation. Such anti-inflammatory actions would be likely to improve the insulin M A N U S C R I P T
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16 resistance associated with obesity in addition to the well-characterised metabolic actions of AMPK. Accordingly AMPK in adipose tissue is a therapeutic target worthy of further investigation. 
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